AIDS
Conditions
Interventions
Blank control group:Routine interventions include free condom distribution, health education and regular HIV testing.
Routine intervention group:Oral Lamivudine tenofovir tablets 300mg and 300mg per day + electronic medicine box (bottle) compliance monitoring + routine interventions.
Intelligent medication reminder group:Routine intervention group + APPs intelligent reminder. APPs intelligent reminder system will include the following parts: 1. Compliance monitoring of electronic
3. Seve
Sponsors
Chongqing Medical University
Eligibility
Sex/Gender
Male
Age
15 Years to 69 Years
Inclusion criteria
Inclusion criteria: 1. Men who have sex with men, aged 18-65 years; 2. HIV-uninfected. 3. An average of once or more sexual behavior a week. 4. There were at least three or more sexual partners a month before the trial. 5. The patient has signed the informed consent. 6. Willing to use experimental drugs under the guidance of follow-up arrangements; 7. Willing to participate in the experiment for 36 months.
Exclusion criteria
Exclusion criteria: 1. Those with a history of severe allergic diseases; 2. Patients with severe heart, liver (AST, ALT 1.5 times higher than the normal ceiling), or kidney (BUN, Cr over normal ceiling) or with hematopoietic disorder, hemorrhagic tendency, hemorrhagic diseases; 3. Patients with mental and neurological disorders; 4. Positive HBsAg or anti-HBc through screening; 5. Patients with advanced tumors; 6. Those with poor compliance and hard to complete the treatment; 7. Those whose life is in danger and can not complete the course of treatment; 8. Participated in clinical trials of new drugs or clinical trials of the same variety within 3 months. 9. Immune deficiency.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| New HIV infection rate; | — |
Countries
China
Contacts
Public ContactXiaoni Zhong
Chongqing Medical University
Outcome results
None listed